Download This PaperCOVID-19, Patents and Access to Healthcare: a French Perspective
9 Pages Posted: 31 May 2020
Date Written: May 1, 2020
Abstract
While the coronavirus 19 (COVID-19) pandemic forced a large part of the world's population into quarantine, research into treatment and testing intensified. At the same time, patents have rarely been so much in the forefront: how can we ensure that access to care will not be hindered by patents? Should we opt for an ex-officio license, relax the conditions of this license, or even expropriate the patentees? A bill tabled on April 7, 2020 in the French “Assemblée Nationale” launches discussion in France.
Keywords: COVID-19, ex-officio licenses, compulsory licensing, patent, access to healthcare, France
Suggested Citation: Suggested Citation
Dhenne, Matthieu and Dhenne, Matthieu, COVID-19, Patents and Access to Healthcare: a French Perspective (May 1, 2020). Available at SSRN: https://ssrn.com/abstract=3614409 or http://dx.doi.org/10.2139/ssrn.3614409
Do you have a job opening that you would like to promote on SSRN?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.